Genetic Variants in Interleukin-2 and Risk of Lymphoma among Children in Korea |
Song, Nan
(Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University)
Han, So-Hee (Department of Preventive Medicine, Seoul National University) Lee, Kyoung-Mu (Department of Environmental Health, Korea National Open University) Choi, Ji-Yeob (Department of Biomedical Sciences, Graduate School, Seoul National University) Park, Sue-K (Department of Preventive Medicine, Seoul National University) Jeon, Su-Jee (Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University) Lee, Yun-Hee (Department of Biomedical Sciences, Graduate School, Seoul National University) Ahn, Hyo-Seop (Cancer Research Institute, Seoul National University) Shin, Hee-Young (Cancer Research Institute, Seoul National University) Kang, Hyoung-Jin (Cancer Research Institute, Seoul National University) Koo, Hong-Hoe (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) Seo, Jong-Jin (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) Choi, Ji-Eun (Department of Pediatrics, Seoul Metropolitan Boramae Hospital) Kang, Dae-Hee (Department of Preventive Medicine, Seoul National University) |
1 | Chan KK, Shen L, Au WY, et al (2010). Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells. J Pathol, 221, 164-74. DOI |
2 | Chen BE, Sakoda LC, Hsing AW, et al (2006). Resamplingbased multiple hypothesis testing procedures for genetic case-control association studies. Genet Epidemiol, 30, 495-507. DOI |
3 | Cozen W, Gill PS, Salam MT, et al (2008). Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma. Blood, 111, 3377-82. DOI |
4 | Howlader N, Noone AM, Krapcho M, et al(2011). SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/ csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site. |
5 | Packer BR, Yeager M, Burdett L, et al (2006). SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res, 34, D617-21. DOI |
6 | Rothman N, Skibola CF, Wang SS, et al (2006). Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol, 7, 27-38. DOI |
7 | Seidemann K, Zimmermann M, Book M, et al (2005). Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt- Munster Trial NHL-BFM. 95, J Clin Oncol, 23, 8414-21. DOI |
8 | Skinnider BF, Mak TW (2002). The role of cytokines in classical Hodgkin lymphoma. Blood, 99, 4283-97. DOI ScienceOn |
9 | Baris S, Celkan T, Batar B, et al (2009). Association between genetic polymorphism in DNA repair genes and risk of B-cell lymphoma. Pediatr Hematol Oncol, 26, 467-72. DOI |
10 | Cerhan JR, Wang S, Maurer MJ, et al (2007). Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood, 109, 5439-46. DOI |
![]() |